No products in the cart.
Rabbit Polyclonal Anti-IL-12B p40 antibody (STJ98797)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IHC-P, ELISA
Recommended dilution: WB 1:500-2000; IHC-P 1:50-300; ELISA 1:5000-20000
Recommended protocols: check protocols
Click or hover above images to see image description for Anti-IL-12B p40 antibody.
Check alternative names for the antibodyExpand
|IL12A antibody| IL12B antibody|CLMF p35 antibody|CLMF p40 antibody|Cytotoxic lymphocyte maturation factor 35 kDa subunit antibody|Cytotoxic lymphocyte maturation factor 40 kDa subunit antibody|Interleukin 12 alpha chain antibody|Interleukin-12 beta chain antibody|NK cell stimulatory factor chain 1 antibody|NK cell stimulatory factor chain 2 antibody|NKSF1 antibody|NKSF2 antibody|Anti-IL12 p70 antibody [QS-12p70] (ab25036)
SCBT cat No: sc-53348|sc-53349|sc-57258|sc-1282|sc-365389|sc-374651|sc-7926|
Anti-IL-12B p40 antibody
|Catalogue No.|| |
Anti-IL-12B p40 antibody detects endogenous IL-12B p40.
Synthetic peptide from human protein at AA range: 241-290.
WB, IHC-P, ELISA
|Recommended dilution|| |
WB 1:500-2000; IHC-P 1:50-300; ELISA 1:5000-20000
|Molecular weight|| |
Anti-IL-12B p40 antibody was tube-contained in PBS, pH 7.4, containing 0.02% sodium azide as Preservative and 50% Glycerol.
Anti-IL-12B p40 antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
IL12A antibody, IL12B antibody, CLMF p35 antibody, CLMF p40 antibody, Cytotoxic lymphocyte maturation factor 35 kDa subunit antibody, Cytotoxic lymphocyte maturation factor 40 kDa subunit antibody, Interleukin 12 alpha chain antibody, Interleukin-12 beta chain antibody, NK cell stimulatory factor chain 1 antibody, NK cell stimulatory factor chain 2 antibody, NKSF1 antibody, NKSF2 antibody
|Database links|| |
|Protein function|| |
Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC. .; Associates with IL23A to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis. .
|Involvement in disease|| |
Immunodeficiency 29 (IMD29) [MIM:614890]: A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. IMD29 is characterized by undetectable IL12B secretion from leukocytes. Affected individuals generally present with BCG disease after vaccination in childhood, and at least half also have Salmonella infection. Disease phenotype is relatively mild, and patients have a good prognosis. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Psoriasis 11 (PSORS11) [MIM:612599]: A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
|Protein sequence and domain|| |
Belongs to the type I cytokine receptor family. Type 3 subfamily. ; Contains 1 fibronectin type-III domain. ; Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
|Protein post-translational modifications|| |
Known to be C-mannosylated in the recombinant protein; it is not yet known for sure if the wild-type protein is also modified.
|Protein cellular localization|| |
AntibodyPlus can customize Anti-IL-12B p40 antibody according to your requirement, including bulk product size,etc. Please contact email@example.com. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: